These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications. Clerc OF; Haaf P; Buechel RR; Gaemperli O; Zellweger MJ Curr Radiopharm; 2021; 14(3):273-299. PubMed ID: 33302861 [TBL] [Abstract][Full Text] [Related]
4. Update on the Inflammatory Hypothesis of Coronary Artery Disease. Boland J; Long C Curr Cardiol Rep; 2021 Jan; 23(2):6. PubMed ID: 33409720 [TBL] [Abstract][Full Text] [Related]
6. Inflammation and ischemic heart disease: The next therapeutic target? Vilela EM; Fontes-Carvalho R Rev Port Cardiol (Engl Ed); 2021 Oct; 40(10):785-796. PubMed ID: 34857118 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine. Andreotti F; Maggioni AP; Campeggi A; Iervolino A; Scambia G; Massetti M Eur Heart J Suppl; 2021 Oct; 23(Suppl E):E13-E18. PubMed ID: 34650351 [TBL] [Abstract][Full Text] [Related]
8. Colchicine and myocardial infarction: A review. Akodad M; Sicard P; Fauconnier J; Roubille F Arch Cardiovasc Dis; 2020 Oct; 113(10):652-659. PubMed ID: 32712201 [TBL] [Abstract][Full Text] [Related]
9. Colchicine for the treatment of coronary artery disease. Aimo A; Pascual-Figal DA; Barison A; Cediel G; Vicente ÁH; Saccaro LF; Emdin M; Bayes-Genis A Trends Cardiovasc Med; 2021 Nov; 31(8):497-504. PubMed ID: 33096241 [TBL] [Abstract][Full Text] [Related]
10. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900 [TBL] [Abstract][Full Text] [Related]
11. Inflammation and ischemic heart disease: The next therapeutic target? Vilela EM; Fontes-Carvalho R Rev Port Cardiol (Engl Ed); 2021 Aug; ():. PubMed ID: 34456098 [TBL] [Abstract][Full Text] [Related]
12. [Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]. Hoogeveen RM; Stroes ESG; Cornel JH Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33201620 [TBL] [Abstract][Full Text] [Related]
13. The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease. Roman YM; Hernandez AV; White CM Ann Pharmacother; 2020 Oct; 54(10):1021-1029. PubMed ID: 32425120 [TBL] [Abstract][Full Text] [Related]
14. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview. Nidorf SM; Thompson PL Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. Seropian IM; Toldo S; Van Tassell BW; Abbate A J Am Coll Cardiol; 2014 Apr; 63(16):1593-603. PubMed ID: 24530674 [TBL] [Abstract][Full Text] [Related]
16. Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin. Sardu C; D'Onofrio N; Torella M; Portoghese M; Loreni F; Mureddu S; Signoriello G; Scisciola L; Barbieri M; Rizzo MR; Galdiero M; De Feo M; Balestrieri ML; Paolisso G; Marfella R Cardiovasc Diabetol; 2019 Sep; 18(1):126. PubMed ID: 31570103 [TBL] [Abstract][Full Text] [Related]
17. Colchicine in the Management of Acute and Chronic Coronary Artery Disease. Bouabdallaoui N; Tardif JC Curr Cardiol Rep; 2021 Jul; 23(9):120. PubMed ID: 34269908 [TBL] [Abstract][Full Text] [Related]
18. Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents. Biondi-Zoccai G; Garmendia CM; Abbate A; Giordano A; Frati G; Sciarretta S; Antonazzo B; Versaci F Curr Atheroscler Rep; 2020 Jan; 22(1):4. PubMed ID: 31932973 [TBL] [Abstract][Full Text] [Related]
19. Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction. Li YW; Chen SX; Yang Y; Zhang ZH; Zhou WB; Huang YN; Huang ZQ; He JQ; Chen TF; Wang JF; Liu ZY; Chen YX Cardiovasc Drugs Ther; 2024 Feb; 38(1):31-41. PubMed ID: 35900652 [TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction. Beckwith C; Munger MA Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]